I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Pernille Ofstad, A.
115
results:
Search for persons
X
Format
Online (115)
Mediatypes
Articles (Online) (46)
OpenAccess-fulltext (69)
Languages
english (114)
french (1)
Sorted by: Relevance
Sorted by: Year
?
1
Effets de l'empagliflozine sur les marqueurs de la stéatose..:
Hadjadj, S.
;
Kahl, S.
;
Pernille Ofstad, A.
...
Annales d'Endocrinologie. 82 (2021) 5 - p. 269-270 , 2021
Link:
https://doi.org/10.1016/..
?
2
P2629Early benefits of empagliflozin in patients with type ..:
Pellicori, P
;
Pernille Ofstad, A
;
Fitchett, D
...
European Heart Journal. 40 (2019) Supplement_1 - p. , 2019
Link:
https://doi.org/10.1093/..
?
3
Empagliflozin in patients with type 2 diabetes mellitus and..:
Anker, Stefan D.
;
Sander, Leif-Erik
;
Fitchett, David H.
...
Diabetes Research and Clinical Practice. 186 (2022) - p. 109837 , 2022
Link:
https://doi.org/10.1016/..
?
4
Association Of Kidney And Cardiovascular Outcomes: Insights..:
Sharma, Abhinav
;
Inzucchi, Silvio E.
;
Testani, Jeffrey
...
Journal of Cardiac Failure. 28 (2022) 5 - p. S103 , 2022
Link:
https://doi.org/10.1016/..
?
5
The influence of diagnostic subgroups, patient- and hospita..:
Rye, Cathrine Sæthern
;
Ofstad, Anne Pernille
;
Åsvold, Bjørn Olav
...
PLOS ONE. 19 (2024) 4 - p. e0302181 , 2024
Link:
https://doi.org/10.1371/..
?
6
Impact of empagliflozin on insulin needs in patients with h..:
Talha, Khawaja M.
;
Green, Jennifer
;
Filippatos, Gerasimos
...
Diabetes, Obesity and Metabolism. 26 (2024) 7 - p. 2578-2587 , 2024
Link:
https://doi.org/10.1111/..
?
7
Development of a tool to predict the risk of incident heart..:
Ofstad, Anne Pernille
;
Brunborg, Cathrine
;
Johansen, Odd Erik
...
ESC Heart Failure. 10 (2023) 5 - p. 2807-2815 , 2023
Link:
https://doi.org/10.1002/..
?
8
Kidney and heart failure events are bidirectionally associa..:
Sharma, Abhinav
;
Inzucchi, Silvio E.
;
Testani, Jeffrey M.
...
ESC Heart Failure. 11 (2023) 2 - p. 737-747 , 2023
Link:
https://doi.org/10.1002/..
?
9
Baseline Cardiovascular Risk Factor Control in Patients Wit..:
Balasubramanian, Priyadarshini
;
Kernan, Walter N.
;
Sheth, Kevin N.
...
Stroke. 54 (2023) 8 - p. 2013-2021 , 2023
Link:
https://doi.org/10.1161/..
?
10
Empagliflozin in heart failure with preserved ejection frac..:
Filippatos, Gerasimos
;
Farmakis, Dimitrios
;
Butler, Javed
...
European Journal of Heart Failure. 25 (2023) 7 - p. 970-977 , 2023
Link:
https://doi.org/10.1002/..
?
11
Liver tests, cardiovascular outcomes and effects of empagli..:
Böhm, Michael
;
Butler, Javed
;
Krawczyk, Marcin
...
European Journal of Heart Failure. 25 (2023) 8 - p. 1375-1383 , 2023
Link:
https://doi.org/10.1002/..
?
12
Shifts in KDIGO CKD risk groups with empagliflozin: Kidney-..:
Weingold, Robert
;
Zinman, Bernard
;
Mattheus, Michaela
...
Journal of Diabetes and its Complications. 37 (2023) 11 - p. 108628 , 2023
Link:
https://doi.org/10.1016/..
?
13
Cardiovascular outcomes trial data from EMPA‐REG OUTCOME, C..:
Dar, Moahad S.
;
Wanner, Christoph
;
Marx, Nikolaus
...
Diabetes, Obesity and Metabolism. 25 (2023) 5 - p. 1372-1384 , 2023
Link:
https://doi.org/10.1111/..
?
14
Generalizability of REDUCE-IT eligibility criteria in a lar..:
Verma, Subodh
;
Kosmopoulos, Andrew
;
Bhatt, Deepak L.
...
American Journal of Preventive Cardiology. 15 (2023) - p. 100510 , 2023
Link:
https://doi.org/10.1016/..
?
15
RF16 | PSUN155 Empagliflozin and the risk of nephrolithiasi:
Balasubramanian, Priyadarshini
;
Wanner, Christoph
;
Ferreira, João Pedro
...
Journal of the Endocrine Society. 6 (2022) Supplement_1 - p. A422-A422 , 2022
Link:
https://doi.org/10.1210/..
1-15